{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:48:37Z","timestamp":1794718117343,"version":"4.9.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","award":["124S427"],"award-info":[{"award-number":["124S427"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003010","name":"Ege University","doi-asserted-by":"publisher","award":["23821"],"award-info":[{"award-number":["23821"]}],"id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151390","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:45:02Z","timestamp":1773272702000},"page":"151390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Folic acid-targeted chitosan-alginate blend nanoparticles for enhanced ixabepilone delivery and antitumor efficacy in breast cancer"],"prefix":"10.1016","volume":"354","author":[{"given":"Ay\u00e7a","family":"Mehmeto\u011flu Al","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130skender","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"G\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151390_bb0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151390_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-024-02927-2","article-title":"Development and characterization of olaparib-loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for pharmaceutical applications","volume":"25","author":"Shin","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"09","key":"10.1016\/j.ijbiomac.2026.151390_bb0015","first-page":"118","article-title":"MDR1 haplotypes and G2677T\/A polymorphism predict imatinib response in tunisian patients with chronic myeloid leukemia","volume":"10","author":"Ammar","year":"2022","journal-title":"J. Biosci. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151390_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","article-title":"Radiation therapy for glioblastoma: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology guideline","volume":"35","author":"Sulman","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151390_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3816\/CBC.2007.n.036","article-title":"Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues","volume":"7","author":"Fornier","year":"2007","journal-title":"Clin. Breast Cancer"},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.151390_bb0030","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1158\/1078-0432.CCR-08-0169","article-title":"Microtubule active agents: beyond the taxane frontier","volume":"14","author":"Morris","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/17455057.5.2.115","article-title":"Ixabepilone: a new active chemotherapy in the treatment of breast cancer","volume":"5","author":"Villanueva","year":"2009","journal-title":"Women Health"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151390_bb0040","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-04-3921","article-title":"Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer","volume":"65","author":"Kukowska-Latallo","year":"2005","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151390_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-015-5609-x","article-title":"Synthesis of folate-pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells","volume":"26","author":"Siafaka","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151390_bb0050","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-06-0141","article-title":"Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery","volume":"5","author":"Sinha","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2024.1477724","article-title":"Activated carbon-coated iron oxide magnetic nanocomposite (IONPs@CtAC) loaded with morin hydrate for drug-delivery applications","volume":"12","author":"Do\u011fan","year":"2024","journal-title":"Front. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151390_bb0060","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/00914037.2024.2387026","article-title":"Polymer blends innovation: advancement in novel drug delivery","volume":"74","author":"Bramhe","year":"2025","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"issue":"August","key":"10.1016\/j.ijbiomac.2026.151390_bb0065","article-title":"Polymer-hybrid nanoparticles: current advances in biomedical applications","volume":"131","author":"Ferreira Soares","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmats.2021.752813","article-title":"Polymers blending as release modulating tool in drug delivery","volume":"8","author":"Ghasemiyeh","year":"2021","journal-title":"Front. Mater."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0075","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IJN.S252237","article-title":"Burgeoning polymer nano blends for improved controlled drug release: a review","volume":"15","author":"Maghsoudi","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0080","article-title":"Applications of polymer blends in drug delivery","volume":"7","author":"Nyamweya","year":"2021","journal-title":"Future J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151390_bb0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/1061186X.2024.2374034","article-title":"An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA\/MSN hybrid nanoparticles","volume":"32","author":"Tonbul","year":"2024","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01626-z","article-title":"Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer","volume":"20","author":"Yadav","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151390_bb0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(99)00062-9","article-title":"Targeted drug delivery via the folate receptor","volume":"41","author":"Sudimack","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151390_bb0105","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1007\/s11033-022-08171-w","article-title":"Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast cancer: possible clinical application","volume":"50","author":"Jafari-Gharabaghlou","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151390_bb0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/09205063.2024.2303196","article-title":"Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer","volume":"35","author":"Jamali","year":"2024","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0115","series-title":"Folic acid-conjugated Biopolymeric Nanoparticles for Targeted Delivery of Ixabepilone in Breast Cancer","author":"Al","year":"2026"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151390_bb0120","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0125","series-title":"Guidance for Industry: Q1A(R2) Stability Testing of New Drug Substances and Products, U.S. Department of Health and Human Services, Food and Drug Administration. SubStance, Revision 2, 1\u201322","author":"FDA","year":"2003"},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.151390_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810362","article-title":"Cordycepin inhibits growth and metastasis formation of MDA-MB-231 xenografts in nude mice by modulating the hedgehog pathway","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151390_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/cbt.6.3.3713","article-title":"Weekly administration of paclitaxel induces long-term aneugenicity in nude mice","volume":"6","author":"Galmarini","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0140","doi-asserted-by":"crossref","DOI":"10.1088\/1757-899X\/833\/1\/012073","article-title":"Characterization of alginate-chitosan membrane as potential edible film","volume":"833","author":"Ismillayli","year":"2020","journal-title":"IOP Conf. Ser. Mater. Sci. Eng."},{"issue":"1904","key":"10.1016\/j.ijbiomac.2026.151390_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/073619b0","article-title":"Infra-red spectra","volume":"73","author":"R","year":"1906","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1590\/1980-5373-mr-2016-0509","article-title":"Fibers obtained from alginate, chitosan and hybrid used in the development of scaffolds","volume":"20","author":"Furuya","year":"2017","journal-title":"Mater. Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.151390_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/polym13152575","article-title":"Enhancement of antioxidant and hydrophobic properties of alginate via aromatic derivatization: Preparation, characterization, and evaluation","volume":"13","author":"Elbayomi","year":"2021","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nano.2009.05.004","article-title":"The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity","volume":"6","author":"Yan","year":"2010","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0170","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems - a review (Part 1)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0175","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151390_bb0180","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0190","author":"Board"},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0195","series-title":"Chitosan for Biomaterials I | R. Jayakumar | Springer","author":"Board","year":"2011"},{"issue":"August 2022","key":"10.1016\/j.ijbiomac.2026.151390_bb0200","article-title":"Folic acid-poly(N-isopropylacrylamide-maltodextrin) nanohydrogels as novel thermo-\/pH-responsive polymer for resveratrol breast cancer targeted therapy","volume":"182","author":"Metawea","year":"2023","journal-title":"Eur. Polym. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"issue":"June","key":"10.1016\/j.ijbiomac.2026.151390_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jddst.2018.06.020","article-title":"Folic acid-chitosan-alginate nanocomplexes for multiple delivery of chemotherapeutic agents","volume":"47","author":"Di Martino","year":"2018","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jbm.b.31046","article-title":"Swelling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads","volume":"86","author":"Dai","year":"2008","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151390_bb0220","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1039\/C9RA10792D","article-title":"Synthesis and characterization of magnetic chitosan microspheres for drug delivery","volume":"10","author":"Li","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0168-3659(85)90051-3","article-title":"Kinetics of drug release from hydrogel matrices","volume":"2","author":"Lee","year":"1985","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151390_bb0230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0142-9612(98)00215-4","article-title":"Dimensionless analysis of swelling of hydrophilic glassy polymers with subsequent drug release from relaxing structures","volume":"20","author":"Brazel","year":"1999","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2009.09.011","article-title":"Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis","volume":"141","author":"Ferrero","year":"2010","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151390_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/polym14050936","article-title":"pH-responsive nanocarriers in cancer therapy","volume":"14","author":"Alsawaftah","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","article-title":"Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review","volume":"85","author":"Kanamala","year":"2016","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151390_bb0250","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsami.7b14603","article-title":"Theranostics of triple-negative breast cancer based on conjugated polymer nanoparticles","volume":"10","author":"Jin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.151390_bb0255","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1039\/C5NR01932J","article-title":"In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocomposites","volume":"7","author":"Zeng","year":"2015","journal-title":"Nanoscale"},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151390_bb0260","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1158\/1078-0432.CCR-12-0374","article-title":"Integrin \u03b1v\u03b23-targeted IRDye 800CW near-infrared imaging of glioblastoma","volume":"18","author":"Huang","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0265","doi-asserted-by":"crossref","DOI":"10.1117\/1.2717137","article-title":"Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer","volume":"12","author":"Adams","year":"2007","journal-title":"J. Biomed. Opt."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151390_bb0270","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/acs.molpharmaceut.6b01053","article-title":"Effect of dye and conjugation chemistry on the biodistribution profile of near-infrared-labeled nanobodies as tracers for image-guided surgery","volume":"14","author":"Debie","year":"2017","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1061186X.2024.2393423","article-title":"Folate-conjugated carbon nanotubes as a promising therapeutic approach for targeted cancer therapy","volume":"33","author":"Halwai","year":"2025","journal-title":"J. Drug Target."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.151390_bb0280","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1039\/C5TB00587F","article-title":"Folic acid-conjugated organically modified silica nanoparticles for enhanced targeted delivery in cancer cells and tumor in vivo","volume":"3","author":"Yin","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0285","first-page":"49","article-title":"Preparation and in vitro and in vivo evaluation of technetium- 99m-labeled folate and methotrexate conjugates as tumor imaging agents","volume":"21","author":"Okarvi","year":"2006","journal-title":"Cancer Biother. Radiopharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151390_bb0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.apsb.2016.07.009","article-title":"Tissue distribution and tumor uptake of folate receptor-targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration","volume":"6","author":"Shen","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.151390_bb0295","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2146\/ajhp070628","article-title":"Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer","volume":"65","author":"Goodin","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151390_bb0300","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.110.175604","article-title":"Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-Glycoprotein (P-gp\/MDR1\/ABCB1) but not breast cancer resistance protein (BCRP\/ABCG2)","volume":"337","author":"Shen","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151390_bb0305","series-title":"Y.Lu,P.S.Low_Adv. Drug Deliv. Rev. _(2002).pdf","first-page":"675","volume":"54","author":"Lu","year":"2002"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151390_bb0310","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425247.2012.694863","article-title":"Clinical translation of folate receptor-targeted therapeutics","volume":"9","author":"Teng","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/1061186X.2017.1339194","article-title":"Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer","volume":"26","author":"Erdo\u011far","year":"2018","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151390_bb0320","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1080\/10717544.2021.1960926","article-title":"Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer","volume":"28","author":"Guo","year":"2021","journal-title":"Drug Deliv."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:58:56Z","timestamp":1774288736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026013164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"alternative-id":["S0141813026013164"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151390","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folic acid-targeted chitosan-alginate blend nanoparticles for enhanced ixabepilone delivery and antitumor efficacy in breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151390"}}